Stock Analiz

ARGX vs BIIB stock comparison

Argenx vs. Biogen · data as of November 13, 2026

Argenx (ARGX) has a market value of about $59.6B, Biogen (BIIB) about $37.5B. Over their latest twelve months Argenx had revenue of $5.8B and Biogen $10.3B.

On our five checks Argenx scores higher: 2.4 out of 5 (weak) against 1.8 (weak).

By area, the stronger company is Biogen on value; Argenx on future growth; Argenx on track record; Argenx on financial health.

Argenx is cheaper on earnings (P/E 33.2 vs. 109.2).

Argenx leads on 12 of the compared lines and Biogen on 8.

Side by side

ARGXBIIB
Size and price
Market cap$59.6B$37.5B
Share price$960.04$253.40
Score
Overall score (of 5)2.41.8
Value01
Future growth42
Track record21
Financial health54
Shareholder returns11
Valuation
P/E (TTM)33.2109.2
Forward P/E31.517.4
Price / free cash flow193.018.1
Price / sales10.23.6
EV / EBITDA28.626.7
PEG——
DCF value vs. price−72%−33%
Business
Revenue$5.8B$10.3B
Net income$1.9B$348M
Free cash flow$309M$2.1B
Net margin32.2%3.4%
Gross margin (5-yr avg.)90.8%76.9%
ROIC (5-yr avg.)-7.0%9.2%
Growth
Revenue growth (1 yr)88.6%2.2%
Revenue growth (5 yrs, per year)130.8%-6.0%
EPS growth (5 yrs, per year)—-18.7%
Balance sheet and payouts
Net cash (cash minus debt)$5.1B-$6.1B
Dividend yieldNoneNone
Shareholder yield0.0%0.0%
Analysts
Upside to average target+19%+6%
Consensus ratingBuyBuy

Highlighted = the better figure on that line. Revenue, net income and free cash flow: ARGX TTM to September 30, 2026, BIIB TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, Argenx or Biogen?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Argenx scores 2.4 out of 5 and Biogen 1.8; the table shows where each one is stronger.

Is Argenx cheaper than Biogen?

On trailing earnings, Argenx trades at a P/E of 33.2 and Biogen at 109.2, so Argenx is cheaper by this measure. A lower P/E can also reflect slower expected growth.

Which grows faster, Argenx or Biogen?

Over five years Argenx grew revenue about 130.8% a year and Biogen about -6.0% a year.

Full Argenx analysis → Full Biogen analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.